Biotechnology commercialization in Europe
Keywords:commercialisation, biotechnology, technology transfer, spin-off
AbstractEuropean biotechnology was mapped for research and commercialisation from various information sources. Social and economical benefits from technology transfer in biotechnology are clearly visible in those European countries where proper attention is given to bioscience entrepreneurship education alongside with scientific base creation and spin-off development. Successful bioscience commercialisation is a result of a coordinated support of research and specific commercialisation programmes leading to spinoff establishment and industry partnership.
How to Cite
Ukropcová, D., & Šturdík, E. (2021). Biotechnology commercialization in Europe. Nova Biotechnologica Et Chimica, 9(3), 255-264. https://doi.org/10.36547/nbc.1134
Copyright (c) 2021 Nova Biotechnologica et Chimica
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.